CBIO FY 2014 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$327M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+276.4% YoY

Gross Profit

$15M100.0% margin

Operating Income

-$11M-74.1% margin

Net Income

-$11M-74.0% margin

EPS (Diluted)

$-0.60

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$57M

Total Liabilities

$6M

Stockholders' Equity

$51M

Cash & Equivalents

$55M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$4M	+276.4%
Gross Profit	$15M	$4M	+276.4%
Operating Income	-$11M	-$11M	-5.0%
Net Income	-$11M	-$11M	-4.9%